Aarey Drugs & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Aarey Drugs & Pharma	Lyka Labs	BDH Inds
Operational Metrics
Financials
5 yr Average ROE	4.4 %	68.98 %	14.8 %
5yr average Equity Multiplier	2.28	2.9	1.46
5yr Average Asset Turnover Ratio	1.58	0.73	0.89
5yr Avg Net Profit Margin	1.23 %	-0.79 %	11.59 %
Price to Book	1.46	2.25	2.69
P/E	63.34	0.0	19.14
5yr Avg Cash Conversion Cycle	60.21 Days	32.55 Days	-27.79 Days
Inventory Days	21.8 Days	24.2 Days	31.79 Days
Days Receivable	122.43 Days	92.33 Days	116.74 Days
Days Payable	103.05 Days	106.74 Days	156.43 Days
5yr Average Interest Coverage Ratio	3.59	2.2	78.47
5yr Avg ROCE	8.53 %	25.83 %	19.81 %
5yr Avg Operating Profit Margin	1.54 %	24.02 %	14.91 %
5 yr average Debt to Equity	0.22	1.25	0.1
5yr CAGR Net Profit	-9.19 %	n/a	7.83 %
5yr Average Return on Assets	1.94 %	1.72 %	10.19 %
Shareholdings
Promoter Holding	37.71 %	58.16 %	49.7 %
Share Pledged by Promoters	0.0	0.0	8.99 %
Change in Promoter Holding (3 Yrs)	-12.33 %	7.16 %	0.04 %
Change in Mutual Fund Holding (3 Yrs)	0.0	-3.3 %	0.0

	Aarey Drugs & Pharma	Lyka Labs	BDH Inds
Product Wise Break-Up	Product Wise Break-Up Formulations 0 Bulk Drugs 0 Others 100	Product Wise Break-Up Formulations 96.8 Bulk Drugs 3.2	Product Wise Break-Up Formulations 0 Bulk Drugs 0 Others 100